SELLAS Life Sciences Group (SLS)
Develops licensed oncology candidates GPS and SLS009 for cancer indications.
$11.84
vs last close+0.46 (+4.09%)
Something off on this page? Send us feedback.
Next report
Nov 11, 26
in 50 days
EPS estimate
−$0.05
Revenue estimate
—
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported−$0.08−$0.07−$0.07−$0.06−$0.05−$0.05−$0.05Pending
Estimate−$0.11−$0.10−$0.08−$0.06−$0.06−$0.06−$0.05−$0.05
Surprise+27.3%+30.0%+16.0%+5.3%+21.0%+16.7%−11.1%—
RevenueReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported———————Pending
Estimate————————
Surprise————————
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec 2027 | −$0.05 | — | — |
| Sep 2027 | −$0.05 | — | — |
| Jun 2027 | −$0.05 | — | — |
| Mar 2027 | −$0.05 | — | — |
| Dec 2026 | −$0.05 | — | — |
| Nov 2026 | −$0.05 | — | — |
| Aug 2026 | −$0.05 | −$0.05 | −11.1% |
| May 2026 | −$0.06 | −$0.05 | +16.7% |
| Mar 2026 | −$0.06 | −$0.05 | +21.0% |
| Nov 2025 | −$0.06 | −$0.06 | +5.3% |
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Mar 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Mar 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Mar 2021 | |||
| Nov 2020 | |||
| Aug 2020 | |||
| May 2020 | |||
| Mar 2020 | |||
| Nov 2019 | |||
| Aug 2019 | |||
| May 2019 | |||
| Mar 2019 | |||
| Nov 2018 | |||
| Aug 2018 | |||
| May 2018 | |||
| Apr 2018 | |||
| Nov 2017 | |||
| Aug 2017 | |||
| May 2017 | |||
| Mar 2017 | |||
| Nov 2016 | |||
| Aug 2016 | |||
| May 2016 | |||
| Mar 2016 | |||
| Nov 2015 | |||
| Aug 2015 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Dec 2027 | −$0.05 | — | — | $0 | — | — | — |
| Sep 2027 | −$0.05 | — | — | $0 | — | — | — |
| Jun 2027 | −$0.05 | — | — | $0 | — | — | — |
| Mar 2027 | −$0.05 | — | — | $0 | — | — | — |
| Dec 2026 | −$0.05 | — | — | $36.1M | — | — | — |
| Nov 11, 2026 | −$0.05 | — | — | $0 | — | — | — |
| Aug 11, 2026 | −$0.05 | −$0.05 | −11.1% | — | — | — | +6.5% |
| May 12, 2026 | −$0.06 | −$0.05 | +16.7% | — | — | — | −0.6% |
| Mar 19, 2026 | −$0.06 | −$0.05 | +21.0% | — | — | — | +5.1% |
| Nov 12, 2025 | −$0.06 | −$0.06 | +5.3% | — | — | — | −1.3% |
| Aug 12, 2025 | |||||||
| May 13, 2025 | |||||||
| Mar 20, 2025 | |||||||
| Nov 13, 2024 | |||||||
| Aug 13, 2024 | |||||||
| May 14, 2024 | |||||||
| Mar 28, 2024 | |||||||
| Nov 9, 2023 | |||||||
| Aug 10, 2023 | |||||||
| May 11, 2023 | |||||||
| Mar 16, 2023 | |||||||
| Nov 14, 2022 | |||||||
| Aug 11, 2022 | |||||||
| May 12, 2022 | |||||||
| Mar 31, 2022 | |||||||
| Nov 12, 2021 | |||||||
| Aug 12, 2021 | |||||||
| May 13, 2021 | |||||||
| Mar 23, 2021 | |||||||
| Nov 13, 2020 | |||||||
| Aug 13, 2020 | |||||||
| May 14, 2020 | |||||||
| Mar 13, 2020 | |||||||
| Nov 14, 2019 | |||||||
| Aug 14, 2019 | |||||||
| May 15, 2019 | |||||||
| Mar 22, 2019 | |||||||
| Nov 15, 2018 | |||||||
| Aug 15, 2018 | |||||||
| May 15, 2018 | |||||||
| Apr 13, 2018 | |||||||
| Nov 9, 2017 | |||||||
| Aug 14, 2017 | |||||||
| May 10, 2017 | |||||||
| Mar 15, 2017 | |||||||
| Nov 9, 2016 | |||||||
| Aug 9, 2016 | |||||||
| May 10, 2016 | |||||||
| Mar 10, 2016 | |||||||
| Nov 9, 2015 | |||||||
| Aug 6, 2015 |